Abnormal liver transaminases and conjugated hyperbilirubinemia at presentation of acute lymphoblastic leukemia

Pediatric Blood and Cancer

Volumn 55, Issue 3, 2010, Pages 434-439

  Segal, Idit ^a   Rassekh, S Rod ^a   Bond, Mason C ^a   Senger, Christof ^b   Schreiber, Richard A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

ALL; ALT; AST; Hepatitis; Hyperbilirubinemia; Jaundice; Leukemia

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; ASPARAGINASE; ASPARTATE AMINOTRANSFERASE; DAUNORUBICIN; STEROID; VINCRISTINE; BILIRUBIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; AGE; ARTICLE; CANCER INVASION; CANCER PATIENT; CHILD; CHILDHOOD LEUKEMIA; CLINICAL FEATURE; FEMALE; HEPATITIS; HUMAN; HYPERBILIRUBINEMIA; LEUKOCYTE COUNT; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; T CELL LEUKEMIA; TREATMENT OUTCOME; ADOLESCENT; BLOOD; ENZYMOLOGY; INFANT; LIVER; PATHOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; CHILD; CHILD, PRESCHOOL; HEPATITIS; HUMANS; HYPERBILIRUBINEMIA; INFANT; LIVER; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 77955485950     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22549     Document Type: Article

References (24)

1. Möricke A, Reiter A, Zimmermann M, et al. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: Treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood 2008;1114477-1114489.
2. Margolin JF, Steuber CP, Poplack DG. Acute lymphoblastic leukemia. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology, 5th edition. Lippincott Williams & Wilkins; 2006. pp.538-590.
3. Frei E, Frtiz RD, Price E, et al. Renal and hepatic enlargement in acute leukemia. Cancer 1963;16:1089-1092.
4. Zimmerman HJ. Hepatotoxic effects of oncotherapeutic agents. In: The adverse effect of drugs and other chemicals on the liver. New York: Appleton-Century-crofts; 1979. pp.621-642.
5. Harb JM, Werlin SL, Camitta BM, et al. Hepatic ultrastructure in leukemic children treated with methotrexate and 6-mercaptopurine. Am J Pediatr Hematol Oncol 1983;5:323-331.
6. Relling MV, Crom WR, Pieper JA, et al. Hepatic drug clearance in children with leukemia: Changes in clearance of model substrates during remission-induction therapy. Clin Pharmacol Ther 1987;41:651-660.
7. Felice MS, Hammermuller E, De Davila MT, et al. Acute lymphoblastic leukemia presenting as acute hepatic failure in childhood. Leukemia Lymphoma 2000;38:633-637.
8. Sulkes A, Collins JM. Reappraisal of some dosage adjustment guidelines. Cancer Treat Reports 1987;71:229-233.
9. Yang RZ, Park S, Reagan WJ, et al. Alanine aminotransferase isoenzymes: Molecular cloning and quantitative analysis of tissue expression in rats and serum elevation in liver toxicity. Hepatology 2009;49:599-607.
10. Krier M, Ahmed A. The asymptomatic outpatient with abnormal liver function tests. Clin Liver Dis 2009;13:167-177.
11. McCord RG, Gilbert EF, Joo PJ. Acute leukemia presenting as jaundice with acute liver failure. Clin Pediatr 1973;12:17-20.
12. Conway EE, Santorineou M, Mitsudo S. Fulminant hepatic failure in a child with acute lymphoblastic leukemia. J Pediatr Gastroenterol Nutr 1992;15:194-197.
13. Devictor D, Fabre M, Mielot F, et al. Early pre B acute lymphoblastic leukemia presenting as fulminant liver failure. J Pediatr Gastroenterol Nutr 1996;22:103-106.
14. Kelleher JF, Monteleone PM, Steele DA, et al. Hepatic dysfunction as the presenting feature of acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2001;23:117-121.
15. Alvaro F, Jain M, Morris LL, et al. Childhood acute lymphoblastic leukemia presenting as jaundice. J Pediatr Child Health 1996;32:466-468. (Pubitemid 26365003)
16. Mori T, Sugita KI, Suzuki T, et al. Histopathologic features of the biopsied liver at the onset of childhood B precursor acute lymphoblastic leukemia presenting as severe jaundice. J Pediatr Gastroenterol Nutr 1997;25:354-357.
17. Levendoglu-Tugal O, Bannan M, Slim M, et al. Acute lymphoblastic leukemia presenting as leukemic hepatitis. Int J Pediatr Hematol Oncol 1999;6:89-93.
18. Scheimberg IB, Pollock DJ, Collins PW, et al. Pathology of the liver in leukemia and lymphoma. A study of 110 autopsies. Histopathology 1995;26:311-321.
19. Gough A, Chapman S, Wagstaff K, et al. Minocycline induced autoimmune hepatitis and systemic lupus erythematosus like syndrome. Br Med J 1996;312:169-172. (Pubitemid 26026289)
20. Bhat G, Jordan J, Sokalski SDO, et al. Minocycline induced hepatitis with autoimmune features and neutropenia. J Clin Gastroenterol 1998;27:74-75.
21. Squires RH. Acute liver failure in children. Semin Liver Dis 2008;29:153-166.
22. Gonzalez-Vallina R, Alonso EM, Rand E, et al. Outpatient percutaneous liver biopsy in children. J Pediatr Gastroenterol Nutr 1993;17:370-375.
23. Cohen MB, Kader HHA, Lambers D, et al. Complications of percutaneous liver biopsy in children. Gastroenterology 1992;102:629-632.
24. Children's Oncology Group trials AAAL0232, AALL0331 CCG 1991, CCG 1991 protocols. Available online at www.childrensoncologygroup.org.